Objective:

To highlight the efficacy and benefits of orthokeratology (ortho-k) in slowing myopia progression in children and teenagers.

Key Findings:

• Ortho-k slows axial elongation and vitreous chamber depth by approximately 50%.
• The greatest benefit is observed in children aged 6 to 8 years.
• Ortho-k is effective in managing myopia with moderate to high astigmatism.
• It can also address anisometropia effectively.
• Combination treatment with atropine shows enhanced efficacy.

Interpretation:

Ortho-k is a robust option for myopia management, offering significant benefits in slowing progression and improving quality of life for children.

Limitations:

• The adaptation effects of treatment may limit long-term efficacy.
• The majority of safety data is derived from adult studies.

Conclusion:

Ortho-k remains a vital tool in myopia management, with a strong evidence base and the ability to tailor treatment to individual needs.